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Abstract
Background: The provision of high-quality maternity services is a priority for reducing inequalities in health outcomes for
mothers and infants. Best practice includes women having their initial antenatal appointment within the first trimester of
pregnancy in order to provide screening and support for healthy lifestyles, well-being and self-care in pregnancy. Previous
research has identified inequalities in access to antenatal care, yet there is little evidence on interventions to improve early
initiation of antenatal care. The Community REACH trial will assess the effectiveness and cost-effectiveness of engaging
communities in the co-production and delivery of an intervention that addresses this issue.
Methods/design: The study design is a matched cluster randomised controlled trial with integrated process and
economic evaluations. The unit of randomisation is electoral ward. The intervention will be delivered in 10 wards;
10 comparator wards will have normal practice. The primary outcome is the proportion of pregnant women attending
their antenatal booking appointment by the 12th completed week of pregnancy. This and a number of secondary
outcomes will be assessed for cohorts of women (n = approximately 1450 per arm) who give birth 2–7 and 8–13
months after intervention delivery completion in the included wards, using routinely collected maternity data. Eight
hospitals commissioned to provide maternity services in six NHS trusts in north and east London and Essex have been
recruited to the study. These trusts will provide anonymised routine data for randomisation and outcomes analysis. The
process evaluation will examine intervention implementation, acceptability, reach and possible causal pathways. The
economic evaluation will use a cost-consequences analysis and decision model to evaluate the intervention. Targeted
community engagement in the research process was a priority.
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Discussion: Community REACH aims to increase early initiation of antenatal care using an intervention that is
co-produced and delivered by local communities. This pragmatic cluster randomised controlled trial, with integrated
process and economic evaluation, aims to rigorously assess the effectiveness of this public health intervention, which is
particularly complex due to the required combination of standardisation with local flexibility. It will also answer questions
about scalability and generalisability.
Trial registration: ISRCTN registry: registration number 63066975. Registered on 18 August 2015.
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Background
Inequalities in maternal and infant mortality and mor-
bidity are a challenge for public health policy and service
delivery worldwide. In the UK the provision of high-
quality maternity services is a priority for reducing
national inequalities in health outcomes throughout
pregnancy, birth and the subsequent life course of the
mother and infant [1]. Antenatal care is the first step in
maternity service provision for the pregnant woman.
Antenatal care refers to the package of health care ser-
vices provided throughout pregnancy, from conception
to the onset of labour, and includes monitoring the
health of the woman and fetus, providing medical and
psycho-social support, and health promotion [2]. Under-
utilisation of antenatal care is associated with adverse
pregnancy outcomes including low birth weight, neo-
natal mortality and maternal mortality [3, 4]. Current
national guidelines recommend that women have a first
contact (with a midwife or GP) followed by an antenatal
care booking appointment with a maternity service
within the first trimester of pregnancy (and ideally by 10
weeks), in order to fully benefit from the available
screening, interventions and support [5]. At the first
contact the focus is on the provision of antenatal
information and screening. The ‘booking appointment’
involves a health check and taking a medical history,
information on nutrition and exercise, information on
and offers of appropriate screening tests, as well as sup-
port for well-being and self-care in pregnancy. The
booking appointment is also important for identifying
women with social and medical risk factors so that these
can be appropriately managed throughout the maternity
pathway [6].
The timing of the booking appointment is associated
with the quality and availability of health services, and
the socio-demographic characteristics of pregnant
women [2]. The percentage of women who attend their
booking appointment by 12 completed weeks of
pregnancy within each National Health Service (NHS)
maternity service is an indicator used by the UK
Department of Health to monitor local and national in-
equalities in the provision and uptake of antenatal care
[7]. Women from minority ethnic groups are less likely
to have their booking appointment by the 12th com-
pleted week of pregnancy, in comparison to white
women [8, 9]. Late booking is also associated with socio-
economic deprivation [10]. This delayed initiation of
antenatal care for many pregnant women living in mar-
ginalised communities is attributed to lower levels of
health literacy within these communities (in relation to
knowledge regarding the purpose and importance of
antenatal care, and understanding of the health care sys-
tem), along with reduced autonomy, resources and
support to make use of the health care services that are
available [11–13].
A systematic review by Oakley et al. [2] of interven-
tions to increase early access to antenatal care for so-
cially disadvantaged groups of women concluded that
there was a lack of good-quality evidence on the effect-
iveness of such interventions, with no randomised
controlled trials identified in this area. Interventions that
were noted by the reviewers as potentially applicable to
the UK setting and worthy of further development and
examination included community-based programmes,
where lay women are trained to provide information on
antenatal care and its availability to women within their
communities. A review by Hollowell et al. [13], that
focussed on barriers to early initiation of antenatal care
by women from minority ethnic communities in the UK,
called for the development of interventions that promote
the purpose and benefit of early and continued antenatal
care in ways that take into account the cultural beliefs
and practices of groups at risk of late booking. These
authors further emphasised the need for information
about antenatal care to be provided in a proactive and
accessible format for women who may not be familiar
with the UK health care system, or who may not speak
English as their first language.
Community engagement to increase early initiation of
antenatal care
Community engagement has been broadly defined as the
‘direct or indirect process of involving communities in
decision-making and/or in the planning, design,
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governance and delivery of services, using methods of
consultation, collaboration, and/or community control’
[14, 15]. It is thus an umbrella term for a variety of ap-
proaches and methods. In recent years, community
engagement has been increasingly recognised as import-
ant in national policy and strategy documents for health
service delivery, public health promotion and the reduc-
tion of health inequalities [16, 17]. Theories of commu-
nity engagement suggest that involving communities as
partners in the planning, design and delivery of interven-
tions for health improvement leads to more appropriate
and accessible interventions, and increased sense of
ownership of the interventions and health outcomes
[18]. A recent review of community engagement ap-
proaches to reducing health inequalities found them to
be effective in improving health behaviours, health con-
sequences, participant self-efficacy and perceived social
support for disadvantaged groups [14]. Community
engagement strategies that have targeted disadvantaged
pregnant women and new mothers have been found to
be most effective when peer delivery or collaborative
models are used in interventions [19]. Community
development is an example of a collaborative model in
which communities and other organisations work
together to co-produce locally focussed activities, by
building on existing relationships and assets within
communities.
Despite the recent policy focus on utilising local
strengths, knowledge and resources of communities to
co-produce and deliver interventions for health and
well-being, there have been few trials of the effectiveness
of such interventions [20] and community engagement
is not yet routinely embedded in mainstream commis-
sioning and practice. Very few studies have looked at
community engagement interventions in relation to
antenatal care [19].
This paper presents the study protocol (version 2;
22.1.16) for the first cluster randomised controlled trial of
a community-centred intervention that seeks to increase
early initiation of antenatal care in communities where
women are more likely to experience late initiation of
antenatal care. The intervention uses community-
engagement approaches, including community develop-
ment and peer delivery, as part of a locally focussed ‘whole
systems’ approach, which will engage and mobilise com-
munity assets (e.g. local health care professionals such as
midwives, nurses and general practitioners (GPs), faith
groups, local businesses) and enhance local people’s
capabilities to provide advice and information in relation
to health within their own communities.
Development of the Community REACH study
In 2010, members of the study team received UK
National Institute for Health Research (NIHR)
Programme Development Grant funding (Grant
Reference Number RP-PG-1211-20,015) to carry out
exploratory research that would lead to the development
of a new intervention to improve early initiation of ante-
natal care in urban settings with social disadvantage and
ethnic diversity. We worked in an East London borough
which has the largest proportion of births to mothers
who were not born in the UK, at 76.4% [21]. Through
epidemiological analysis, socio-demographic and clinical
predictors of delayed access to antenatal care in this bor-
ough were identified [8]. Women identified as most vul-
nerable to late access included those: from ethnic
minority communities; unable to speak English; born
outside of the UK; with more than two children.
Qualitative research uncovered several barriers to timely
antenatal care attendance that corresponded to those
identified in the academic literature outlined above [12].
Barriers identified included: difficulties navigating the re-
ferral system, especially if women were not already regis-
tered with a GP or had limited or no English; lack of
understanding regarding the value and benefits of early
antenatal care; lack of agency and sense of entitlement
to health care. As part of a public engagement focussed
research process [22] a stakeholder workshop was held
to plan for intervention development. This brought to-
gether maternity service users, maternity service
managers, local health care commissioners, representa-
tives of community organisations, and the research team.
Workshop participants emphasised that the new inter-
vention ought to work collaboratively with women:;
building on women’s networks, empowering women,
and harnessing local volunteering.
The Community REACH study was developed as a re-
sult of this exploratory work with stakeholders. It will
test a local, focussed whole systems intervention which
aims to (1) raise awareness in local communities of the
value of antenatal care and its early uptake and (2) sup-
port women in how and when to access care, with the
longer term aim to change local social norms which will
sustain any increase in women’s early access of antenatal
care. The intervention uses a co-production process to
engage local communities in: identifying their percep-
tions/views on the issues and solutions to increase early
booking for antenatal care; tailoring the design of the
intervention and form and content of key intervention
messages; and facilitating the communication of the
intervention messages through community self-help and
local social networks. Our community engagement team
will work with a co-host community organisation already
established in each site, to support and implement the
intervention at the local level. Peer volunteers, who are
women from the local target community, will be
recruited and trained for the role of ‘antenatal care
champions’ to deliver the intervention messages through
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engagement with women and wider family members,
and local community groups and organisations (ranging
from faith groups to pharmacies). A particular focus will
be on reaching women from the groups identified
through our previous epidemiological analysis to be
most vulnerable to late initiation of antenatal care. The
theoretical framework for the intervention is informed
primarily by the concepts of community engagement
and health literacy; the latter is defined as ‘the cognitive
and social skills which determine the motivation and
ability of individuals to gain access to, understand and
use information in ways which promote and maintain
good health’ [23]. Critically, the concept of health
literacy goes beyond the ability to read health informa-
tion and navigate health services, by increasing access
to, and the ability and motivation to act on, health
information. Figure 1 displays the theory of change in
the form of a logic model for the Community REACH
intervention.
The Community REACH study is one component of a
wider programme of research, the REACH (Research for
Equitable Antenatal Care and Health) Pregnancy
Programme. With high priority given to public and prac-
titioner involvement, the Programme is focussed on
improving access to, and experience of, antenatal care
(Hayes 2012) [22]. The University of East London (UEL)
is the lead academic partner. Organisations working with
UEL on the Community REACH study include:
University College London (UCL) Institute of Education
providing trials expertise and management; the
Pragmatic Clinical Trials Unit (PCTU) at Queen Mary
University of London providing data management, stat-
istical support and quality assurance; UCL conducting
the economic evaluation. Uscreates, a design agency
with a social focus, supported the initial co-design and
communication strategy of the intervention. The study
runs from 1 April 2015 (when NHS Research Ethics
Committee approval was received) to 11 October 2019
(the end date of the REACH Pregnancy Programme).
This paper was written after funding and approvals were
received for the Community REACH study, participating
NHS trusts were enrolled, randomisation of study sites
and co-design workshops were completed, but prior to
the intervention set-up and collection of any trial data.
Methods/design
Study design
The study design is a two-armed, matched cluster ran-
domised controlled trial, with integral process and
economic evaluations, see Figs. 2 and 3 and Additional
Fig. 1 Logic model for the Community REACH intervention
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Fig. 2 Flow chart of the trial
Fig. 3 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) schedule
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file 1, which present the study flow chart, the Standard
Protocol Items: Recommendations for Interventional
Trials (SPIRIT) schedule of enrolment, interventions
and assessments and SPIRIT Checklist, respectively [24].
This design was selected because the interventions are
delivered at the community rather than individual level.
The unit (cluster) of randomisation and intervention de-
livery is electoral ward.1 All outcomes are measured
using anonymised routinely collected maternity data.
The trial includes 20 electoral wards with high delayed
rates of initiation of antenatal care, reflecting high rates
of inequality in the ward populations. Ten wards were
randomised to intervention and 10 to control, matched
by these initiation rates and by pattern of use of hospi-
tals in each ward.
Randomised trial design has traditionally required
standardisation (or fidelity) of intervention delivery
across experimental sites, but the effectiveness of
community-based interventions is likely to depend upon
whether they are responsive to local needs and contexts
[25]. The Community REACH trial is one of a small, but
growing, number of cluster-randomised controlled trials
of community-led complex public health interventions,
where the function and general approach of the inter-
ventions are standardised across study sites, but the
exact nature of each intervention is adapted at the
community level to suit the local context [20].
Study population
The study population is women in the selected electoral
wards who give birth, at a hospital enrolled in the study,
over a 12-month period. The timing of this period will
be determined by the delivery of the intervention; all
women in control and intervention sites will be included
if they give birth 2–13 months after the intervention
delivery has ended in intervention sites. There will be no
active recruitment of participants to this trial as out-
comes will be measured using anonymised routinely
collected maternity services data. Individuals will be re-
cruited to the integral process evaluation and this is
described below.
Inclusion and exclusion criteria
The unit of randomisation is electoral ward. Inclusion
criteria for electoral wards (clusters) are:
 Where the proportion of women who have their
first appointment for antenatal care with the
maternity service by the 12th completed week of
pregnancy is below the NHS national target of 90%,
using data collected prior to randomisation over a
6-month period within each hospital
 Where historically the majority of pregnant women
have chosen to access the maternity services of the
commissioned maternity care provider for the area
in which they live (i.e. the service participating in
the study), as opposed to services provided by
another NHS trust
Exclusion criteria are:
 Where the proportion of women who have their
first appointment for antenatal care with the
maternity service by the 12th completed week of
pregnancy is 90% or above
 Where it is common for pregnant women to access
maternity services other than those provided by the
hospitals participating in the study
Recruitment and selection of clusters for randomisation
For both substantive and pragmatic reasons NHS trusts
in north and east London and Essex were targeted for
recruitment to the study. The inclusion of an out of
London area (Essex) is intended to enhance the general-
isability of findings. Six NHS trusts agreed to take part,
from which eight hospitals providing NHS maternity
care (three providers from one large trust) enrolled in
the study. NHS trusts were required to commit to pro-
viding routine maternity data for randomisation and
assessment of outcomes as part of the participation
agreement. Any trust unable to commit to this was not
able to participate.
The research team identified 20 electoral wards eligible
to include in the study, distributed across the geographical
areas served by the participating hospitals. This identifica-
tion process required informatics staff, already responsible
for managing routine maternity data in each participating
hospital, to extract retrospective ‘gestation at booking’
data for women using the maternity services of these hos-
pitals during a defined recent 6-month period. Routinely
this maternity data is organised by postcode. In order to
render it non-identifiable for study purposes, the inform-
atics staff converted the postcode data to its correspond-
ing electoral ward name using a postcode-to-ward
database sourced from local authorities and provided to
the informatics staff by the research team. Informatics
staff transferred the data to the research team in a dedi-
cated study database sent in an encrypted form via email.
A pilot of this data transfer procedure was completed in
one hospital, in order to ensure that all processes could be
operationalised and audited.
From the databases of electoral wards, we selected 10
pairs of wards that met the eligibility criteria, ensuring
that no wards neighboured one another to minimise
intervention/control site contamination. Each pair of
wards was matched on the hospitals accessed and base-
line rate of antenatal booking by the 12th completed
week of pregnancy, categorised as very low (≤ 70%) or
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low (71–89%). A matched pair consisted of either two
‘very low’ wards or two ‘low’ wards, with similar patterns
of hospital usage by women seeking antenatal care. An
independent member of the research team, who was not
involved in the recruitment of the trusts, oversaw the
decision on the final list of 20 sites to ensure that the
risk of selection bias was minimised. Each selected site
was allocated a unique ID code, which was used in place
of electoral ward names for randomisation purposes.
Randomisation, blinding and retention
Matched randomisation, of the 10 pairs of electoral wards
with 1:1 ratio was undertaken remotely by the Pragmatic
Clinical Trials Unit (PCTU) at Queen Mary’s University
London (QMUL) using Stata software (version 12;
StataCorp, College Station, TX, USA). The research team
were informed of the results of the allocation by secure
email using a password-protected file.
As with most social intervention trials, those involved in
delivering the intervention in the clusters (i.e. the electoral
wards) cannot be ‘blinded’ to allocation status. Informatics
staff in the participating services were given the names of
the selected wards in their area but were not actively
informed of the results of the randomisation.
Given the nature of this trial, sites cannot drop out of
the trial, unless an NHS trust withdraws from the study.
We aim to work closely with local site principal investi-
gators (PI) to ensure that this does not occur. The use of
routine data for assessment of outcomes means limited
missing data can be expected. Data sets provided for the
site selection process (described above) confirmed this
to be the case; as such no consideration of how to deal
with missing data is indicated.
The intervention
The Community REACH intervention will be delivered
in the 10 intervention sites (electoral wards), with each
component of the intervention tailored to the local com-
munity thereby tapping into local assets and addressing
local cultural beliefs and motivational barriers, and com-
munity perceived needs and solutions.
Phase 1: Mapping, community engagement and co-design
In developing the intervention plans the research team
prepared a profile/map for each intervention site, in
relation to current referral pathways to antenatal care,
demographic information and community assets.
Midwives working in the area provided local knowledge
on barriers to accessing services. Staff from the design
agency Uscreates and members of the UEL community
engagement team then spent 2–3 days engaging with
local people in each intervention site (through speaking
to people at community facilities, marketplaces and
other areas of local footfall). Local women and other
family members were asked about experiences of ante-
natal care, perceived importance of antenatal care and
their thoughts and opinions on the local area. A co-de-
sign workshop was held in each intervention site, facili-
tated by Uscreates. Local women who had registered
their interest in the project during the street
engagement, outlined above, were invited to attend,
along with representatives from local community organi-
sations and midwives working locally. Attendees partici-
pated in exercises to stimulate creativity and worked
collaboratively on developing ideas for key messages,
materials and events to improve early uptake of ante-
natal care in the local area.
Workshop participants highlighted the need for
greater information about referrals to antenatal care, the
services that are available, and the purpose and benefits
of antenatal care. They felt that this information ought
to be provided through local connections, networks and
languages, i.e. women from the community engaging
with other local women about antenatal care. In re-
sponse to workshop outputs, a co-produced community-
based intervention will be prepared and implemented in
each site, as outlined below:
Phase 2: Set-up and training (3 months)
1. The intervention will be centrally co-ordinated by a
community engagement team at UEL. A co-host
community organisation will be recruited within
each intervention site to support the local delivery of
the intervention. Co-host organisations must meet
certain criteria in order to be involved, for example:
experience of managing, supporting and developing
outreach teams; demonstrable experience of working
with vulnerable groups including black and ethnic
minority communitie; strong links to local community
groups and organisations and statutory health services
2. Six to eight local people will be recruited in each site
as voluntary antenatal care champions, to engage
directly and indirectly with women and families, and
specific groups and organisations from their
community, to raise awareness of the value and
benefits of early antenatal care and how and when
to access care. The antenatal care champions will
receive training for this role (which will involve
input from a midwife) on the antenatal care system,
including referral pathways and the purpose and
benefits of antenatal care. Champions will also be
trained in presentation and communication skills,
ongoing practice reflection, adult and child
safe-guarding, and health and well-being coaching
3. Co-host organisations and antenatal care champions
in each site will work collaboratively with the UEL
community engagement team and the research team
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to build on the detailed profiles and mapping of
community assets for each intervention site, and to
further develop their local outreach plans for
intervention implementation, which will engage the
whole system within each ward (e.g. schools,
children’s centres, GPs, pharmacies, faith groups)
4. A communications strategy and materials for the
intervention messages, based on the outputs from
the co-design workshops will be developed. The co--
host organisations and antenatal care champions will
also be part of the decision-making about whether
and how the intervention messages ought to be tai-
lored for each site
Phase 3: Implementation (6 months)
Implementation of the intervention will take place, in each
of the sites, immediately after the development phase. As
this will be co-produced and locally tailored, the outreach
and engagement plans in each site may vary.
Antenatal care champions are likely to engage with
their local communities about antenatal care, particu-
larly women who are vulnerable to later service access,
through: presenting and discussing information with
groups (e.g. at community events, evening classes, faith
groups); one-to-one sessions, where antenatal care
champions will engage with local people directly and
indirectly in places of high footfall (e.g. GP surgeries,
pharmacies, shopping centres); informal, opportunistic
outreach, building on existing networks and relation-
ships within the community.
We will use a staggered approach, with implementa-
tion taking place first in three ‘pathfinder’ sites before
starting in the remaining seven sites, in order that inter-
vention development and delivery can benefit from some
initial learning.
The comparator
Normal maternity care promotion and practice will con-
tinue in the 10 electoral wards randomised to the con-
trol arm. All participating providers of maternity
services are free to engage in additional actions to en-
hance early booking of antenatal care that affect popula-
tions in the electoral wards in either arm of the study.
Outcome measures
Based on the hypothesis that the intervention will pro-
mote earlier booking of care, particularly by those most
at risk of late booking (as per the pathways shown in
Fig. 1), the primary outcome is the proportion of
pregnant women in each ward who have attended their
antenatal booking appointment by the end of the 12th
completed week of their pregnancy. Secondary outcome
measures are: the proportion of women who have
attended their antenatal booking appointment by 10
weeks and 0 days of pregnancy; antenatal admissions;
emergency caesarean rates; gestation and weight at deliv-
ery; smoking at booking appointment and at birth; feed-
ing method at discharge. Outcomes will be measured
using anonymised routine hospital data. Outcomes data,
covering periods of 6 months, will be extracted by trust
informatics staff at three time points. These time points
are as follows: time point 1 (baseline) – women giving
birth who were at least 13 weeks pregnant at the point
that any intervention-related activities commenced; time
point 2 (first follow-up) – women giving birth 2–7
months after the end of intervention delivery; time point
3 (second follow-up) – women giving birth 8–13 months
after the end of intervention delivery. Further data on
age, ethnicity, housing tenure, parity and deprivation will
be provided along with the outcomes data.
The study will not require names, NHS numbers,
dates of birth, addresses or postcodes. In order to ensure
complete anonymisation, trust informatics staff will re-
code potentially identifying individual level data; for
example, age and ethnicity, into broad categories, ensur-
ing this categorisation does not compromise any pro-
posed analyses. The name of each electoral ward will be
replaced by a unique ward-specific ID code that is not
known to staff in the PCTU who will be analysing the
data. In addition, an unblinded member of the PCTU
data management team will liaise with informatics staff
in each trust to ensure that secure data transfer methods
are understood and used when transferring data from
the trust to the PCTU. They will then make the data ac-
cessible to their data management colleagues who will
remain blind to study site. The data management team
will ensure the secure storage of study datasets for stat-
isticians to conduct their analysis. A pilot of the out-
comes data transfer process will be conducted across the
study sites to ensure that procedures are deliverable by
informatics staff and fit for purpose. A collaborative ap-
proach involving the research team, informatics staff and
site PIs, to finalising the exact list of outcomes and the
data transfer processes will be taken.
Power and sample size
In our Programme Development Grant research, we
analysed routine data from the maternity service at
Newham University Hospital, which contained the cor-
responding postcode for each pregnancy in Newham
from the period April 2007 to January 2011. We calcu-
lated by ward the variation in cluster size and the
proportion accessing antenatal care by the 12th com-
pleted week of pregnancy as the basis for estimation of
intra-cluster correlation coefficient and our sample size
calculation. To detect an increase in antenatal booking
by 12 weeks gestation from 75% to 82%, with 90% power
at the 5% significance level requires at least 751
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individuals in each trial arm. To account for clustering
(ICC = 0.005, mean cluster size 145, matching correl-
ation = 0.1) requires nine clusters in the intervention
group and in the control group, which equates to 1450
women per trial arm. Because this sample size is rela-
tively small, and to guard against a substantial loss of
power if a cluster is lost for any reason, we added one
cluster to each group. As described, pairs of clusters
were matched by the hospital used by those in the ward
seeking maternity care and by baseline rate of antenatal
booking by 12 weeks. This has been measured per ward
and collected pre-randomisation.
Process evaluation
Ongoing formative evaluation work will be conducted
alongside Phases 1 and 2 of the intervention, in order to
inform the development of the intervention structure,
activities and materials. Research team members will
conduct observations and interviews to document and
analyse the activities in each intervention site during the
stages of community engagement, co-design, interven-
tion set-up and training of antenatal care champions.
The UEL community engagement team will provide
records on intervention set-up in each site, and co-host
organisations will provide records on recruitment of
antenatal care champions.
A process evaluation will be conducted for Phase 3 of
the intervention, to explore its implementation. This in-
tegral process evaluation will run alongside the impact
evaluation.
Process data will be used to examine intervention im-
plementation, acceptability and reach, issues of context,
as well as hypothesise possible causal pathways, in order
to facilitate interpretation of outcome data. In line with
recent Medical Research Council (MRC) guidance on
process evaluations for complex interventions [26], this
component of the trial will also enable refinement of the
intervention logic model (see Fig. 1).
The process evaluation has four specific components.
These are:
1. Documentation and analysis of the local social
contexts in intervention and control sites
The mapping process described above in Phase 1 of
the intervention will be expanded by the research team
to document and analyse the local social context of the
intervention and control sites and their main maternity
providers, in order to identify events and influences that
may hinder or support intervention implementation, or
affect study outcomes. Information will also be recorded
on all previous and current interventions/innovations re-
garding antenatal care that have been developed by
maternity services, local authorities or community
organisations for people living in the study sites
2. Documentation and analysis of intervention
activities
Intervention activities will be documented and ana-
lysed for each site. Members of the research team will
observe up to two purposively selected events in each of
the intervention sites, where antenatal care champions
engage with their local community about antenatal care.
The UEL community engagement team and the co-host
organisations will provide detailed records of interven-
tion delivery and progress.
3. Interviews with antenatal care champions, co-host
representatives and other stakeholders
The experiences of those taking part in the co-
production and delivery of the intervention, and their
perceptions regarding its impact on their communities,
will be explored through qualitative research interviews.
Up to 40 people, across three to four intervention ‘case
study’ sites (final numbers dependent on data satur-
ation), will be purposively sampled for individual inter-
views. Participants will be interviewed at the beginning
and again towards the end of the intervention delivery
phase. In the first interview, interviewees will be asked
about their motivations for getting involved with the
intervention, their expectations for how the intervention
may be received within their local communities, their
experiences and perspectives on the training process,
and their early experiences with delivering the interven-
tion messages around antenatal care. The second fol-
low-up interview will be conducted with each
participant approximately 6 months following their first
interview, to address experiences with delivering the
intervention and perceived intervention acceptability
within the community. We will also aim to conduct in-
terviews with those who cease their involvement with
the intervention delivery while it is ongoing, in order to
explore reasons for stopping. Interviews will also be con-
ducted with local community midwives to gain insight
into local maternity service provision and local barriers/
enablers around access to antenatal care within the
intervention site. Interviewees will receive a £10 voucher
as reimbursement for their time. The qualitative re-
search interviews will explore the social contexts within
which the intervention is implemented, building a richer
picture of intervention delivery and mechanisms of im-
pact. The number of interviews to conduct in the
remaining intervention sites, and who to interview, will
be decided pragmatically and judiciously based on the
findings from earlier sites.
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4. Survey to assess exposure to the intervention and its
influence
A sample of 400 women across the 20 trial sites will
be surveyed to assess reach, exposure to and acceptabil-
ity of the intervention. The survey will be conducted
with women attending appointments at antenatal book-
ing clinics 3 months following the start of the imple-
mentation of the intervention. We will aim to conduct
this with an approximate ratio of 3:1 intervention to
control women surveyed. Hospital staff will identify eli-
gible women, when they attend the clinic, based on their
postcode. Women who agree to participate, will be pro-
vided with the survey in written, self-administered form,
with the offer of researcher or bilingual health advocate
support where required. The survey will be translated
into other languages that are common to women using
that particular maternity service. The survey will not
contain sensitive or personal questions regarding the
woman’s pregnancy, but rather will focus on the
woman’s first point of contact in her antenatal care path-
way, whether she had heard of the intervention and
whether it had any effect on her decision-making about
the timing of antenatal care initiation. Participants will
receive a £5 voucher as a ‘thank you’ for their
participation.
Women who would like additional time to make a de-
cision about participation in the survey will be provided
with a link to an online version that they can complete
at a future date. On completion they will be invited to
send their address by email to the research team in
order that a £5 voucher can be posted to them.
Economic evaluation
A cost-consequences economic evaluation, will evaluate
the effectiveness of the community-based intervention
compared to current practice. Information collected dur-
ing the process evaluation will be used to calculate the
cost of the intervention for each ward including develop-
ment and implementation costs. Health care resource
use, collected for both trial arms, will include: antenatal
bookings and appointments; antenatal admissions; mode
of delivery with a focus on emergency cesareans; costs
associated with pre-term births and low birth weight,
maternal and infant deaths.
Analysis
Trial outcomes
A cluster-level analysis, appropriate to the analysis of
matched cluster randomised trials, will be used with the
maternity care providers for the NHS trusts participating
in the study as fixed effects. We will use intention to
treat principles. We will include individual level prog-
nostic covariates if appropriate and ward-level estimates
of baseline levels of outcomes as covariates. These will
be chosen in advance of any analyses being conducted
and documented in a full analysis plan. In additional
analyses we will explore the use of instrumental variable
techniques to incorporate some process measures as me-
diators of effect. Our primary analyses will consider
primary and secondary outcomes data pertaining to
births in the period 2–7 months post intervention start.
Further secondary analyses will be conducted using data
for births in the period 8–13 months post intervention
completion to explore the maintenance of any effects
and trends. A small number of sub group analyses may
also be conducted using Stata software (version 14;
StataCorp, College Station, TX, USA).
Process evaluation
All qualitative interview data will be managed and coded
using QSR International’s NVivo 11 qualitative data ana-
lysis software. Interview data will be subjected to
thematic analysis. Codes will be applied to transcripts, to
identify key themes and how these inter-relate in order
to develop an analytical framework. Each transcript will
also be coded to indicate the type of participant and
electoral ward allowing analytical themes to be explored
in relation to different groups’ experiences and to com-
pare processes across intervention areas. Drawing on
methods associated with ‘grounded theory’, constant
comparisons will be made and deviant cases examined
to refine the analysis.
Observation data will be recorded on a semi-
structured proforma. Thematic analysis of this data will
also be undertaken.
Data from the surveys will be analysed using the
current version of IBM SPSS statistical software.
Descriptive analysis will be conducted to assess the key
themes relating to awareness and level of involvement
with the intervention, attitudes towards it, and views on
antenatal care.
Economic evaluation
Costs and health care resource will be reported along-
side primary and secondary outcomes for each trial arm.
Missing data will be assumed to be missing at random
and available case analysis used following the principles
set out in the statistical analysis plan. We will report
95% confidence intervals calculated using bootstrapping.
A decision analytic model will also be developed to
extrapolate the outcomes collected, antenatal admissions
and emergency caesarean, their impact on costs and health
outcomes and costs published in the literature for pre-term
and low weight births. We will use a simplified decision
analytical model to look at the benefits and disadvantages
of the intervention, including the impact on the 12th
completed week of pregnancy target, to assist NHS trusts
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with decisions about implementation; synthesising informa-
tion from other sources where at all possible.
Safety and trial conduct
There are no anticipated risks to study participants or to
those involved with the intervention and the first out-
comes data collection will occur after the intervention
delivery is complete. Therefore, there will be no Data
Monitoring Committee for this trial. This decision, made
by the chief investigator (AH) and members of the Trial
Steering Committee (TSC; see below), is due to the reli-
ance on routine monitoring data that is provided at
source in non-identifiable form. However, as in all inter-
ventions, there may be unanticipated risks and harms
will be assessed through examination of outcomes at the
two time points.
The UK MRC Guidelines on good clinical practice in
trials [27] will be followed. The University of East
London, the employer of AH, will act as the sponsor of
this trial. The trial will be overseen by a TSC. This group
will meet face to face once a year and will be responsible
for overseeing the trial, ensuring scientific quality and
clinical relevance, and adherence to ethics and research
governance. All key collaborators on the trial will attend
the TSC, as well as a range of experts who are not dir-
ectly involved in the trial, including a chair with relevant
expertise, a statistician and an economist. There will also
be a maternity service user representative on the TSC.
Bi-monthly trial management meetings, with the PCTU,
will be held and study team meetings, involving AH,
MW, MS, LS and CS, will take place once a month to
oversee day-to-day progress.
Dissemination
The findings of the trial will be presented at national and
international conferences (e.g. Royal Colleges of Midwives
annual conference, the International Confederation of
Midwives Congress and relevant national public health
conferences). They will also be published in peer-reviewed
academic journals and in professional and practitioner
journals. Findings will also be made available on the study
website and in newsletters. Briefing papers to health care
commissioners and managers and to service users via
Maternity Voices Partnerships, will be prepared. We will
use links with the Reproductive and Childbirth topic net-
work to further disseminate throughout the NHS.
Discussion
The Community REACH trial is one of a growing num-
ber of randomised controlled trials of public health
interventions. The antenatal intervention being tested in
the trial builds on evidence of effectiveness of lay or
peer-delivered interventions when using community
engagement strategies to provide health interventions to
vulnerable or disadvantaged populations. A number of
elements of the study will aid generalisability and scal-
ability if effectiveness is shown. These elements include
the integrated process and economic evaluations, the
range of participating providers of maternity care in the
trial, the flexibility of the intervention and the central in-
volvement of local community members and community
organisations. The application of a cluster randomised
controlled trial design to the testing of an intervention
that combines standardisation of overall approach with
adaption to the local context will make a valuable contri-
bution to the existing body of work on study design, as
will the use of routine hospital data for outcomes ana-
lysis and the collaborative approach to research
processes. If the intervention is shown to be effective it
will be of benefit to those who received it and to society
generally, in terms of improved health and associated re-
duction in cost to society and the NHS.
Trial status
The study protocol reported here is version 2 (22 January
2016). There will be no active recruitment of participants
to this trial as outcomes will be measured using anon-
ymised routinely collected maternity services data.
Individuals will be recruited to the integral process evalu-
ation; recruitment began in June 2017 and is expected to
finish in June 2018.
Endnotes
1An electoral ward in England is a subdivision of a
local authority area, typically used for electoral purposes.
Additional file
Additional file 1: SPIRIT Checklist: evaluation of community-level
interventions to increase early initiation of antenatal care in pregnancy:
Protocol for the Community REACH study, a cluster randomised
controlled trial with integrated process and economic evaluations.
(DOC 122 kb)
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